Welcome to Paid Research Studies


Browse Locations ... United States» ... Massachusetts» ... Cambridge





  • Condition:   Asymptomatic Microscopic Hematuria
    Intervention:   Drug: Estradiol Ring
    Sponsors:   Boston Urogynecology Associates;   Beth Israel Deaconess Medical Center;   Mount Auburn Hospital
    Recruiting - verified February 2017

  • Conditions:   Urinary Incontinence;   Urinary Bladder, Overactive;   Lower Urinary Tract Symptoms
    Intervention:   Other: Preprocedure Telephone Call
    Sponsor:   Boston Urogynecology Associates
    Recruiting - verified February 2017

  • Conditions:   Cystoscopy;   Phenazopyridine
    Intervention:   Drug: Phenazopyridine
    Sponsor:   Boston Urogynecology Associates
    Recruiting - verified February 2017

  • Conditions:   Circulating Tumor DNA;   Cancer;   Neoplasms;   Genomic Testing;   Genomic Alterations
    Intervention:  
    Sponsors:   Foundation Medicine;   Johns Hopkins University;   Oncology Consultants;   Comprehensive Blood and Cancer Center;   Illinois CancerCare;   Sanford Health;   Eastchester Center for Cancer Care;   Rutgers Cancer Institute of New Jersey;   Cone Health;   Nebraska Cancer Specialists;   University of California, Davis;   University of Chicago;   Northeast Georgia Medical Center;   Hematology Oncology Associates of Fredericksburg;   Memorial Sloan Kettering Cancer Center;   Oncology Hematology Care, Inc;   Montefiore Medical Center;   Quincy Medical Group;   Greenville Health System;   Mary Crowley Cancer Research Center;   Texas Health;   University of California, San Diego;   Avera Cancer Institute
    Recruiting - verified February 2017

  • Conditions:   Obstetrical Lacerations;   Obstetric; Injury Pelvic Floor
    Intervention:   Behavioral: Pelvic floor physical therapy
    Sponsor:   Boston Urogynecology Associates
    Recruiting - verified February 2017

  • Condition:   Myofascial Pelvic Pain
    Interventions:   Drug: Intervention-Botulinum Toxin Type A;   Drug: placebo
    Sponsors:   Boston Urogynecology Associates;   Allergan
    Recruiting - verified February 2017

  • Conditions:   Multiple Sclerosis;   Exposure During Pregnancy
    Interventions:   Drug: dimethyl fumarate;   Drug: Peginterferon beta-1a;   Drug: Dalclizumab High Yield Process
    Sponsor:   Biogen
    Recruiting - verified February 2017

  • Conditions:   Non-Small Cell Lung Cancer;   Anemia;   Cancer;   Lung Cancer
    Interventions:   Drug: darbepoetin alfa 500 mcg Q3W;   Drug: placebo
    Sponsor:   Amgen
    Recruiting - verified February 2017